Fidelity Investments
OPTR

Fidelity Investments’s OPTIMER PHARMACEUTICALS, INC. COM STK OPTR Stock Holding History

Fidelity Investments’s Portfolio OPTR Stock Details OPTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-2,642,094
Closed -$33.3M – 2781
2013
Q3 		$33.3M Sell
2,642,094
-2,103,867
-44% -$27.9M 0.01% 1467
2013
Q2 		$68.7M Buy
+4,745,961
New +$69.1M 0.01% 1096

Fidelity Investments's OPTR Position: Q4 2013 in Review

Fidelity Investments sold out of OPTIMER PHARMACEUTICALS, INC. COM STK (OPTR) in Q4 2013, closing a stake of 2,642,094 shares — an estimated $33.3M sold.

Fidelity Investments first reported a position in OPTR in Q2 2013 and held it in 2 quarters. The position peaked at $68.7M in Q2 2013. 0 funds tracked by Wall St. Rank hold OPTR as of Q4 2013.

  • Fidelity Investments reported no remaining OPTIMER PHARMACEUTICALS, INC. COM STK position as of Q4 2013 after selling out during the quarter.
  • Fidelity Investments sold 2,642,094 OPTIMER PHARMACEUTICALS, INC. COM STK shares in Q4 2013, an estimated $33.3M.
  • Fidelity Investments first reported a position in OPTIMER PHARMACEUTICALS, INC. COM STK in Q2 2013 and held it in 2 quarters.
  • Fidelity Investments's OPTIMER PHARMACEUTICALS, INC. COM STK position peaked at $68.7M in Q2 2013.
  • 0 funds tracked by Wall St. Rank held OPTIMER PHARMACEUTICALS, INC. COM STK as of Q4 2013.

Based on Fidelity Investments's 13F filing for Q4 2013, filed 13 Feb 2014.